Pressbox: BioTeSys GmbH

BioTeSys receives ISO 9001:2000 certification

"ISO certification is an important milestone for BioTeSys"

(PresseBox) Esslingen, 19.05.2009, BioTeSys GmbH today announced the new DIN EN ISO 9001:2000 certification for the service portfolio consisting of analytical HPLC based services, cell based test systems
and clinical studies. Esslingen, Germany, November 14, 2008:

“The ISO certification is an important milestone for BioTeSys”, says Dr. Ju?rgen Bernhardt, CEO of BioTeSys GmbH. “I am sure it will further increase the confidence in our high quality service portfolio and our ability to support our customers in substantiation of scientific argumentation. And, we are committed to constantly improve our quality managementsystem.” Certification of conformity to ISO 9001:2000 for the analytical, in vitro- and in vivo-services was by the national certification body DEKRA on December 03, 2008. ISO 9001 certification has become the global benchmark for providing assurance about the ability to satisfy quality requirements and to enhance customer satisfaction in supplier-customer relationships.

About BioTeSys GmbH

About BioTeSys GmbH:

BioTeSys GmbH (www.biotesys.de) is based in Esslingen and was founded in 1999
as a spin-off of the Institute of Biological Chemistry and Nutrition of the University
of Hohenheim. Biotesys is a partner in the development and implementation of new
concepts in the cosmetic, food and consumer health care/OTC sector. The range of ser-
vices includes screening methods for measuring the bioactive potential of substances
or substance mixtures, in-vitro test procedures using single cell cultures, co-cultures
and various organotypic culture models, as well as clinical trials. BioTeSys has been
certified according to ISO 9001:2000. Additionally, the analytical chemistry division
with the main focus on HPLC and photometry has been accredited according DIN
EN ISO/IEC 17025:2005. All measuring methods and test parameters used in tests
have been developed and optimized with regard to physiological criteria. The results
and determined effective concentrations are therefore of direct significance for the
assessment of biological effects.
As complete service provider for the biological and chemical analysis sector the com-
pany offers a wide range of services including the development of new methods and
products on behalf of the client.

As complete service provider in the area of the biological and chemical analysis, the company offers extensive services including the development of new procedures and products for the customer.

Further press release of this company

• 16.01.2012 - BioTeSys selects Logos Technologies ALPHADAS eSource and pro-active...
• 20.09.2011 - BioTeSys – 10 Jahre Analyse- und Forschungs-dienstleistung für...
• 08.04.2011 - BioTeSys – Zehn Jahre Analyse- und Forschungs-dienstleistung...
• 08.04.2011 - BioTeSys – Zehn Jahre Analyse- und Forschungsdienstleistung für...
• 23.02.2011 - BioTeSys – 10 Jahre Analyse- und Forschungs¬dienstleistung für...
• 17.02.2011 - BioTeSys: Zehn Jahre Analyse- und Forschungsdienstleistung für...